Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway. Clinics [Internet]. 2015 Apr. 1 [cited 2024 May 2];70(4):250-6. Available from: https://www.revistas.usp.br/clinics/article/view/100991